Anticoagulants
The best tips and advice from our vast library of articles, videos, and business tools
Browse Related Topics
Free Industry Resources
Newly Added Articles
- Hong Kong shares higher in technical bounce;...
- BUSINESS BRIEFS
- Lloyd Lowndes Beatty Sr.
- Lost in murky waters
- Sling media aims for cable TV certification
- Banks may lose tax cuts
- Financial Mail, London, financial queries column
Search Results
1-20 of 134 related articles
According to recent research from Singapore, Singapore, "Recent reports of catheter thrombosis among patients undergoing percutaneous coronary intervention...
unaggregatedarticle
Washington Editor ImaRx Therapeutics Inc., which is working on anti-clotting therapies, filed for an estimated $75 million initial...
unaggregatedarticle
Dabigatran vs warfarin: Less bleeding? Source: Connolly SJ, et al. Dabigatran versus warfarin in patientswith atrial fibrillation. N...
unaggregatedarticle
PHILADELPHIA - Warfarin, one of the most inconvenient, dangerous and disliked drugs in the world, has remained vitally...
unaggregatedarticle
Staff Writer Emisphere Technologies Inc. said Tuesday that its Phase III trial of oral heparin failed to show...
unaggregatedarticle
West Coast Editor With the way apparently clearing for approval of its low-molecular-weight heparin, Momenta Pharmaceuticals Inc. raised...
unaggregatedarticle
Staff Writer Redirecting its resources toward core anti-inflammatory programs, Inflazyme Pharmaceuticals Inc. dropped development of an antithrombotic agent...
unaggregatedarticle
"Several studies have attempted to identify predictors of outcome following ischaemic stroke. Reduced stroke severity has been reportedwith...
unaggregatedarticle
Science Editor It improves outcomes for patients, but for Genentech Inc. 's Activase itself, the outcome has not...
unaggregatedarticle
"Dietary vitamin K is thought to be an important factor that interferes with anticoagulation stability, but the clinical...
unaggregatedarticle
Staff Writer Thrombolytic drug developer Imarx Therapeutics Inc. priced its initial public offering lower than expected, selling 3...
unaggregatedarticle
"SCH-530348 is a novel antiplatelet agent undergoing development by Schering-Plough Corp for the treatment and prevention of atherothrombosis....
unaggregatedarticle
According to a study from Prague, Czech Republic, "The aim of the study was to assess the regression...
unaggregatedarticle
West Coast Editor Portola Pharmaceuticals Inc. kicked off a Phase II trial with its oral Factor Xa inhibitor...
unaggregatedarticle
Science Editor It's old news that the biggest perpetrator of severe disease and premature death in Western societies...
unaggregatedarticle
Back in the dim days of black-and-white television, one over-the-counter product that was frequently advertised claimed to help...
unaggregatedarticle
o Amgen Inc., of Thousand Oaks, Calif., said its board authorized additional repurchases of up to $5 billion...
unaggregatedarticle
o Agennix Inc., of Houston, said it completed the safety portions of two Phase I/II cancer trials of...
unaggregatedarticle
Staff Writer Renovis Inc. priced a public offering on Friday that will bring the company $54 million in...
unaggregatedarticle
"No large prospective studies have evaluated the efficacy of fibrinolytic therapy for left-sided prosthetic valve thrombosis, yet it...
unaggregatedarticle
How to Turn Your Business Dream into a Successful Reality
Napa Valley business owners tell Sumer Morenz of D&B Digital TV how they turned passion into bottom-line success.
Franchise Finder
Find your perfect franchise
Choose your location and industry and we'll show you the most relevant franchises.
Sponsored Links
Site Map | Contact Us | FAQs | About Us | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy
Media Kit
Copyright © 1999 - 2009 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.
Get In-Depth Company Information from Hoover's | Buy a D&B Credit Report | What is in Your Company's D&B Credit Report?
Online Business Database | Online Business Information | Sales and Marketing Solutions | Business Mailing Lists | Company Profiles
Online Business Database | Online Business Information | Sales and Marketing Solutions | Business Mailing Lists | Company Profiles
Information and opinions on AllBusiness.com solely represent the thoughts and opinions of the authors and are not endorsed by, or reflect the beliefs of,
AllBusiness.com, its parent company D&B, and its affiliates.
AllBusiness.com, its parent company D&B, and its affiliates.
